Flurbiprofen 8.75 mg lozenges for treating sore throat symptoms: a randomized, double-blind, placebo-controlled study.
about
Efficacy of flurbiprofen 8.75 mg delivered as a spray or lozenge in patients with sore throat due to upper respiratory tract infection: a randomized, non-inferiority trial in the Russian Federation.Improvements in throat function and qualities of sore throat from locally applied flurbiprofen 8.75 mg in spray or lozenge format: findings from a randomized trial of patients with upper respiratory tract infection in the Russian Federation.
P2860
Flurbiprofen 8.75 mg lozenges for treating sore throat symptoms: a randomized, double-blind, placebo-controlled study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Flurbiprofen 8.75 mg lozenges ...... ind, placebo-controlled study.
@en
type
label
Flurbiprofen 8.75 mg lozenges ...... ind, placebo-controlled study.
@en
prefLabel
Flurbiprofen 8.75 mg lozenges ...... ind, placebo-controlled study.
@en
P2093
P2860
P356
P1433
P1476
Flurbiprofen 8.75 mg lozenges ...... ind, placebo-controlled study.
@en
P2093
Adrian Shephard
Bernard P Schachtel
Emily Schachtel
Jeanne Rezuke
Kathleen Sanner
Laurie Savino
Sue Aspley
Timothy Shea
P2860
P304
P356
10.2217/PMT-2015-0001
P577
2016-06-29T00:00:00Z